These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

271 related items for PubMed ID: 16205640

  • 1. E2F1 suppresses skin carcinogenesis via the ARF-p53 pathway.
    Russell JL, Weaks RL, Berton TR, Johnson DG.
    Oncogene; 2006 Feb 09; 25(6):867-76. PubMed ID: 16205640
    [Abstract] [Full Text] [Related]

  • 2. Myc lacks E2F1's ability to suppress skin carcinogenesis.
    Rounbehler RJ, Schneider-Broussard R, Conti CJ, Johnson DG.
    Oncogene; 2001 Aug 30; 20(38):5341-9. PubMed ID: 11536046
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. p19(ARF) is dispensable for oncogenic stress-induced p53-mediated apoptosis and tumor suppression in vivo.
    Tolbert D, Lu X, Yin C, Tantama M, Van Dyke T.
    Mol Cell Biol; 2002 Jan 30; 22(1):370-7. PubMed ID: 11739748
    [Abstract] [Full Text] [Related]

  • 9. The inhibitor of cyclin-dependent kinase 4a/alternative reading frame (INK4a/ARF) locus encoded proteins p16INK4a and p19ARF repress cyclin D1 transcription through distinct cis elements.
    D'Amico M, Wu K, Fu M, Rao M, Albanese C, Russell RG, Lian H, Bregman D, White MA, Pestell RG.
    Cancer Res; 2004 Jun 15; 64(12):4122-30. PubMed ID: 15205322
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. A functional screen identifies hDRIL1 as an oncogene that rescues RAS-induced senescence.
    Peeper DS, Shvarts A, Brummelkamp T, Douma S, Koh EY, Daley GQ, Bernards R.
    Nat Cell Biol; 2002 Feb 15; 4(2):148-53. PubMed ID: 11812999
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. A senescence rescue screen identifies BCL6 as an inhibitor of anti-proliferative p19(ARF)-p53 signaling.
    Shvarts A, Brummelkamp TR, Scheeren F, Koh E, Daley GQ, Spits H, Bernards R.
    Genes Dev; 2002 Mar 15; 16(6):681-6. PubMed ID: 11914273
    [Abstract] [Full Text] [Related]

  • 18. FBXL16 is a novel E2F1-regulated gene commonly upregulated in p16INK4A- and p14ARF-silenced HeLa cells.
    Sato K, Kusama Y, Tategu M, Yoshida K.
    Int J Oncol; 2010 Feb 15; 36(2):479-90. PubMed ID: 20043084
    [Abstract] [Full Text] [Related]

  • 19. p19/Arf and p53 suppress sentinel lymph node lymphangiogenesis and carcinoma metastasis.
    Ruddell A, Kelly-Spratt KS, Furuya M, Parghi SS, Kemp CJ.
    Oncogene; 2008 May 15; 27(22):3145-55. PubMed ID: 18059331
    [Abstract] [Full Text] [Related]

  • 20. INK4a-ARF mutations in skin carcinomas from UV irradiated hairless mice.
    Soufir N, Queille S, Mollier K, Roux E, Sarasin A, de Gruijl FR, Fourtanier AM, Daya-Grosjean L, Basset-Seguin N.
    Mol Carcinog; 2004 Apr 15; 39(4):195-8. PubMed ID: 15057871
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.